Can You Live a Long Life With a Defibrillator?

Most people who receive an implantable cardioverter-defibrillator (ICD) go on to live for many years afterward. In a study tracking nearly 186,000 ICD recipients, the one-year survival rate was 92%, and about two-thirds were still alive at the five-year mark. An ICD does not cure the heart condition that prompted it, but by standing ready to correct a lethal rhythm disturbance in seconds, it buys time that the underlying disease would otherwise steal. How much time depends on a tangle of factors that go well beyond the device itself.

How Much Extra Life an ICD Actually Provides

The clearest evidence on survival benefit comes from an extended follow-up of the landmark MADIT-II trial, which tracked patients with weakened hearts after a heart attack. Over eight years, roughly half of ICD patients had died compared with about 62% of those managed without a device. That translated to about a third lower risk of death in the ICD group, and the benefit persisted even after the first four years, meaning the device kept saving lives well into the long term.

Those numbers need context. An ICD does not prevent heart failure from progressing, cancer from developing, or kidneys from declining. It prevents one specific cause of death: sudden cardiac arrest from a dangerous heart rhythm. If that rhythm never occurs, the device sits quietly. In one study, about 9% of ICD patients died from non-arrhythmic causes without the device ever having fired.

A large real-world dataset of nearly 186,000 patients confirmed that the overall five-year survival after ICD implantation sits around 68%. For patients who received a more complex device that also provides cardiac resynchronization therapy (CRT-D, which helps the heart pump more efficiently in addition to guarding against arrhythmias), five-year survival was somewhat lower at 54%, but those patients typically had more advanced heart failure to begin with.

What Really Determines Your Outlook

The single biggest predictor of how long you live with an ICD is not the device. It is everything else going on in your body. Patients who died without the device ever delivering therapy tended to be older, had worse kidney function, lower blood counts, and more conditions stacked on top of their heart disease, including peripheral vascular disease and prior strokes.

The type of heart disease also matters. Among patients receiving an ICD for prevention, those whose weakened heart resulted from a heart attack (ischemic cardiomyopathy) had roughly 1.8 times the death rate compared to those whose heart muscle was damaged from other causes (non-ischemic cardiomyopathy), even though both groups experienced dangerous arrhythmias at similar rates.

⁴

The evidence on how well ICDs work for these two groups is subtly different. A systematic review and meta-analysis found that ICDs cut sudden cardiac death by more than half regardless of the type of cardiomyopathy. But when a separate analysis looked at broader outcomes including all-cause mortality, the benefit was clearest in ischemic patients. For non-ischemic patients whose heart function remained persistently low, the device still helped, but the signal was weaker and reached statistical significance only in subgroup analyses.

⁵

When the Device Fires, and What That Means

Receiving a shock from your ICD is not a neutral event. It means the device detected and treated a dangerous rhythm, but it also signals that the underlying heart disease may be worsening. A large registry study found that patients who received appropriate shocks or anti-tachycardia pacing (a gentler therapy the device tries first) had roughly double the risk of dying compared to patients whose devices stayed quiet, regardless of whether the ICD was implanted for primary or secondary prevention.

⁶

Inappropriate shocks, where the device fires in response to a non-dangerous rhythm or an electrical artifact, are a separate problem entirely. They are painful, frightening, and carry their own mortality risk. In one analysis, a single inappropriate shock was linked to a 60% higher risk of death, and the risk climbed steeply with each additional shock.

⁷

A separate study from the MADIT-II trial confirmed this pattern: patients who experienced inappropriate shocks had more than twice the likelihood of dying during follow-up.

⁸

These findings do not mean shocks themselves cause death. More likely, needing frequent therapy reflects a sicker heart, and inappropriate shocks signal electrical instability or technical problems that compound an already precarious situation. Either way, working with your electrophysiologist to minimize unnecessary shocks through careful device programming matters for both quality and quantity of life.

Living with the Hardware Over Decades

An ICD is not a one-and-done implant. Batteries run out, leads age, and technology improves. In a large cohort study, the median service life before battery replacement was about six years for standard ICDs and closer to five years for CRT-D devices.

⁹

Each replacement surgery is a minor procedure with low complication rates, but it is still surgery, and for patients who live decades with a device, multiple replacements are expected. An analysis of over 111,000 patients undergoing generator replacement found that device malfunctions and infections were uncommon reasons for the swap, occurring in about 1% of cases each. The more relevant concern was the mortality picture: one-year survival after replacement was about 90%, but five-year survival dropped to 59%, reflecting the aging and worsening health of a population that has lived with serious heart disease for years.

¹⁰

Leads, the wires that connect the device to the heart, are arguably the weakest link in the system. One study tracking leads over more than a decade found that about 15% failed, with the annual failure rate climbing to 20% in leads that were ten years old. The most common problems were insulation wearing out and wire fractures.

¹¹

A more recent study found a somewhat lower cumulative failure rate of about 16% at ten years, but certain lead models had significantly higher failure rates. Leads from specific product advisory groups had roughly a seven-fold higher risk of failure compared to non-advisory leads. The reassuring finding is that no lead-related deaths occurred in the study cohort, even among patients with failed leads, because monitoring and timely intervention caught problems before they became lethal.

¹²

Subcutaneous Devices and Fewer Lead Problems

One of the most meaningful hardware advances in recent years is the subcutaneous ICD, which sits under the skin along the chest wall and does not thread any wires through the veins into the heart. This eliminates the main source of long-term hardware trouble. A meta-analysis of randomized trials and matched studies found that subcutaneous devices had far fewer lead-related complications, with a rate roughly one-seventh that of traditional transvenous devices.

¹³

A long-term clinical comparison put specific numbers on this: lead complications occurred in under 1% of subcutaneous ICD patients versus nearly 12% of transvenous ICD patients.

¹⁴

The tradeoff is that the subcutaneous device cannot deliver anti-tachycardia pacing (the gentle overdrive pacing that can stop certain arrhythmias without a shock) or provide the slow-heart pacing that some patients need. This makes it a good option for younger patients, those with limited vein access, or anyone likely to live long enough to wear out multiple sets of transvenous leads. For patients who need pacing, the traditional system or newer hybrid setups remain necessary.

Exercise, Sports, and Everyday Activity

For years, guidelines told ICD patients to avoid vigorous exercise and competitive sports. That advice has softened considerably, driven by registry data showing it is safer than feared. A multinational registry tracked athletes with ICDs who continued competitive and vigorous sports over a median follow-up of about two and a half years. No one died or needed resuscitation during sports. Some athletes did receive shocks during competition, but the devices terminated every episode successfully.

¹⁵

Programming choices can reduce how often athletes get shocked during activity. Setting a higher heart-rate cutoff for detection, for instance, was associated with fewer total and inappropriate shocks during practice and competition. No athlete in the registry died of an arrhythmia whether or not they received shocks.

¹⁶

A more recent registry specifically looking at subcutaneous ICDs and sports found similar patterns. About 73% of patients in the study were physically active. Appropriate shocks occurred, but three-quarters of them happened at rest, not during exercise. Inappropriate shocks were more evenly split, and T-wave oversensing was the most common trigger during peak activity.

¹⁷

Driving is another concern. Patients face temporary restrictions after implantation and after shock events because of the risk of losing consciousness behind the wheel. Guidelines vary by country and by whether the ICD was placed for primary or secondary prevention, and there is genuine disagreement about how long driving bans should last.

¹⁸

The Psychological Weight of Carrying a Defibrillator

Living a long life with a device that can shock you without warning takes a psychological toll that deserves as much attention as the cardiology follow-ups. A meta-analysis pooling data from nearly 40,000 ICD patients found that about 23% experienced clinically meaningful anxiety, roughly 15% had depression, and about 12% met criteria for post-traumatic stress disorder.

¹⁹

These are not just numbers on a questionnaire. Anxiety about when the next shock might come can lead people to withdraw from activities they used to enjoy, avoid exercise (even when exercise is beneficial), and become hypervigilant about every heartbeat. Among older patients undergoing device replacement, a quarter to a third reported low perceived control over their lives. Those who had been shocked previously reported higher symptom burden.

²⁰

The good news is that targeted psychotherapy works. A pilot study of patients who had experienced multiple shocks found that 83% reported meaningful reductions in anxiety and avoidance behavior after treatment, and none showed signs of PTSD at follow-up.

²¹

Partners and caregivers often fare worse than patients themselves. One study found that anxiety, depression, and perceived illness demands on the family were higher in partners than in the patients carrying the device.

²²

Remote Monitoring Changes the Long Game

Modern ICDs transmit data wirelessly to your clinical team, allowing lead integrity, battery status, arrhythmia logs, and heart failure indicators to be reviewed without an office visit. This is not just a convenience. An economic modeling study based on real-world ICD data estimated that remote monitoring was associated with an increase in life expectancy of about nine months and fewer hospitalizations per year compared to standard in-office follow-up only.

²³

A study from Singapore looking at long-term outcomes confirmed the pattern, finding that ICD patients on remote monitoring had a substantially lower risk of death and fewer heart failure hospitalizations even after adjusting for baseline differences between the groups.

²⁴

The likely explanation is that remote monitoring catches problems earlier: a lead that is starting to degrade, fluid buildup that signals worsening heart failure, or a new arrhythmia that needs medication adjustment. Waiting months between clinic visits for these discoveries costs time that some patients cannot afford.

Reducing Shocks with Catheter Ablation

For patients whose ICDs fire frequently because of recurrent arrhythmias, catheter ablation can target the electrical short circuits causing the problem. A randomized trial comparing ablation to escalated anti-arrhythmic drugs found that the combined outcome of death, arrhythmia storm, or ICD shock occurred in about 59% of ablation patients versus nearly 69% of those on escalated medication.

²⁵

A systematic review and meta-analysis reinforced this, concluding that combining an ICD with catheter ablation lowered the rates of ICD shocks, arrhythmia storms, and cardiovascular hospitalizations compared to drug therapy alone.

²⁶

Fewer shocks means not only less physical pain but also less psychological trauma and, as discussed earlier, potentially lower mortality risk. Ablation is not right for every patient, but for those who are getting shocked repeatedly, it can meaningfully change the experience of living with the device.

Who Gets Access and Who Does Not

Whether you live a long life with an ICD depends partly on whether you get one in the first place, and access is uneven. Despite facing a disproportionate burden of sudden cardiac death, racial and ethnic minority patients in the United States are less likely to be referred to a cardiac specialist, counseled about ICD therapy, and ultimately implanted.

²⁷

A study of heart failure patients found that after adjusting for clinical and hospital factors, women were roughly 40% less likely than men to receive an ICD, and Black patients were about 30% less likely than white patients. The gap was widest for Black women, who were about 44% less likely than white men to receive the therapy.

²⁸

Trends over the last two decades show some narrowing. ICD use among Black patients increased substantially after 2006, and the share of ICDs going to women crept upward from about 24% to nearly 30% over about a decade. But Hispanic patients remained the most underserved group throughout.

²⁹

Planning for the End of Life with an Active Device

One aspect of living with an ICD that rarely gets discussed early enough is what happens when the underlying disease reaches a stage where the device is prolonging dying rather than extending meaningful life. An ICD does not know the difference between a treatable arrhythmia and one that occurs as part of the natural dying process. Without a deliberate conversation about deactivation, patients can receive painful shocks in their final hours or days.

A register-based study found that only about half of ICD patients dying outside of a hospital had their devices deactivated beforehand. Among those who had access to specialist palliative care, the rate was much higher at 78%, but only a small fraction of heart failure patients without a concurrent cancer diagnosis were referred to palliative care in the first place.

³⁰

Deactivation is a straightforward, painless process: a technician holds a magnet or programmer over the device and turns off the shock function. The pacing function can remain on if desired. Having this conversation early, ideally as part of routine advance-care planning, prevents distressing shocks at the end and gives patients control over how their final chapter unfolds. If you have an ICD, it is worth raising the topic with your cardiologist well before any crisis, even if that moment feels far away.